Table 1 Baseline demographic and clinical characteristics of patients with nausea and vomiting after treated with transcatheter arterial chemoembolization (TACE)
Characteristic | Placebo-acupuncture group | Active-acupuncture group | P |
|---|---|---|---|
(n = 70) | (n = 72) | ||
Age (years)a | 57.5 (30–75) | 55.4 (41–77) | 1.000 |
Sex | Â | Â | 0.768 |
 Men | 47 (67.1) | 50 (69.4) |  |
 Women | 23 (32.9) | 22 (30.6) |  |
Diagnosis | Â | Â | 0.492 |
 Primary liver cancer | 15 (21.4) | 19 (26.4) |  |
 Metastatic liver cancer | 55 (78.6) | 53 (73.6) |  |
Chemotherapy | Â | Â | 1.000 |
 Cisplatin-based regimen | 70 (100) | 72 (100) |  |
 Non-cisplatin-based regimen | 0 (0) | 0 (0) |  |
VAS of anorexiab | 1.50 ± 1.67 | 1.79 ± 1.82 | 0.321 |